Letachowicz Krzysztof, Szyber Przemysław, Gołębiowski Tomasz, Kusztal Mariusz, Letachowicz Waldemar, Weyde Wacław, Garcarek Jerzy, Klinger Marian
Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.
Department of Vascular, General and Transplantation Surgery, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.
Semin Vasc Surg. 2016 Dec;29(4):146-152. doi: 10.1053/j.semvascsurg.2016.11.003. Epub 2016 Nov 5.
A cornerstone of hemodialysis treatment is the creation of a functional and durable dialysis vascular access. Every patient with chronic kidney disease should have a plan of renal replacement therapy and access site protection. Factors having a crucial impact on vascular access selection include age, comorbidity, vessel quality, prognosis, dialysis urgency, and surgeon's preferences. Our medical group have reviewed these factors in our patients and, based on recently published data, developed a clinical decision tree for dialysis access in the chronic kidney disease patient. Vascular access care should be patient-centered with the aim to maximize patient survival without loss of vascular access options; and not focused only the primary patency rates of dialysis access procedures.
血液透析治疗的基石是建立一个功能良好且持久的透析血管通路。每位慢性肾脏病患者都应有肾脏替代治疗计划和血管通路保护方案。对血管通路选择有至关重要影响的因素包括年龄、合并症、血管质量、预后、透析紧迫性以及外科医生的偏好。我们的医疗团队已对我们患者的这些因素进行了评估,并根据最近发表的数据,为慢性肾脏病患者的透析通路制定了临床决策树。血管通路护理应以患者为中心,目的是在不丧失血管通路选择的情况下最大限度地提高患者生存率;而不应仅关注透析通路手术的初始通畅率。